Leila Hojat1,2, Ann Avery2, Peter J Greco2,3, David C Kaelber4,5,6. 1. Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA. 2. Department of Medicine, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA. 3. Center for Clinical Informatics Research and Education, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA. 4. Department of Medicine, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA. David.kaelber@case.edu. 5. Center for Clinical Informatics Research and Education, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA. David.kaelber@case.edu. 6. Department of Pediatrics and Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. David.kaelber@case.edu.
Abstract
BACKGROUND: Hepatitis C virus (HCV) infection is a major public health burden, affecting over 4 million people. The Centers for Disease Control and Prevention and the US Preventive Services Task Force guidelines recommend screening everyone born between 1945 and 1965, but screening rates remain low. OBJECTIVE: To determine whether bulk ordering and electronic messaging to patients improves guideline-based HCV screening rates. DESIGN: A non-randomized controlled trial of 1024 adults from November 2016 to March 2017. PARTICIPANTS: Patients due for HCV screening with at least one primary care office visit in one of three primary care clinics and enrolled in the healthcare system's tethered personal health record (tPHR). INTERVENTIONS: Control patients received normal care for HCV screening, consisting of passive HCV reminders to providers during face-to-face visits and passive HCV screening notification through the patient's tPHR. Intervention patients received normal care and also had HCV antibody tests ordered for them and customized messages sent through their tPHR inviting them to go directly to the lab for HCV screening over a 12-week period. MAIN MEASURES: Percentage/number of patients receiving HCV antibody tests during the intervention period. Percentage/number of intervention group patients receiving HCV screening with other blood work. KEY RESULTS: In the intervention group, 33% (168 of 514) completed HCV testing, compared with 19% (97 of 510) of controls (OR 1.7, 95% CI 1.2-2.1). Bulk lab ordering appeared to have a large impact while bulk messaging appeared to have a less significant role. CONCLUSIONS: Leveraging population analytics and bulk ordering in an electronic health record with bulk messaging to a tPHR directly engages patients in blood screening tests and can significantly improve completion. This methodology has a broad range of applications including many recommended screening or disease-specific testing. This bulk ordering and direct-to-patient messaging approach improves patient screening while decreasing provider/staff work. TRIAL REGISTRATION: MetroHealth IRB16-00776 (ClinicalTrials.gov).
RCT Entities:
BACKGROUND:Hepatitis C virus (HCV) infection is a major public health burden, affecting over 4 million people. The Centers for Disease Control and Prevention and the US Preventive Services Task Force guidelines recommend screening everyone born between 1945 and 1965, but screening rates remain low. OBJECTIVE: To determine whether bulk ordering and electronic messaging to patients improves guideline-based HCV screening rates. DESIGN: A non-randomized controlled trial of 1024 adults from November 2016 to March 2017. PARTICIPANTS: Patients due for HCV screening with at least one primary care office visit in one of three primary care clinics and enrolled in the healthcare system's tethered personal health record (tPHR). INTERVENTIONS: Control patients received normal care for HCV screening, consisting of passive HCV reminders to providers during face-to-face visits and passive HCV screening notification through the patient's tPHR. Intervention patients received normal care and also had HCV antibody tests ordered for them and customized messages sent through their tPHR inviting them to go directly to the lab for HCV screening over a 12-week period. MAIN MEASURES: Percentage/number of patients receiving HCV antibody tests during the intervention period. Percentage/number of intervention group patients receiving HCV screening with other blood work. KEY RESULTS: In the intervention group, 33% (168 of 514) completed HCV testing, compared with 19% (97 of 510) of controls (OR 1.7, 95% CI 1.2-2.1). Bulk lab ordering appeared to have a large impact while bulk messaging appeared to have a less significant role. CONCLUSIONS: Leveraging population analytics and bulk ordering in an electronic health record with bulk messaging to a tPHR directly engages patients in blood screening tests and can significantly improve completion. This methodology has a broad range of applications including many recommended screening or disease-specific testing. This bulk ordering and direct-to-patient messaging approach improves patient screening while decreasing provider/staff work. TRIAL REGISTRATION: MetroHealth IRB16-00776 (ClinicalTrials.gov).
Entities:
Keywords:
electronic health records; hepatitis C virus; personal health records; population health management; screening
Authors: Megan G Hofmeister; Elizabeth M Rosenthal; Laurie K Barker; Eli S Rosenberg; Meredith A Barranco; Eric W Hall; Brian R Edlin; Jonathan Mermin; John W Ward; A Blythe Ryerson Journal: Hepatology Date: 2018-11-06 Impact factor: 17.425
Authors: Barbara J Turner; Barbara S Taylor; Joshua T Hanson; Mary Elizabeth Perez; Ludivina Hernandez; Roberto Villarreal; Poornachand Veerapaneni; Kristin Fiebelkorn Journal: J Hosp Med Date: 2015-05-29 Impact factor: 2.960
Authors: Nivedha Panneer; Erik Lontok; Bernard M Branson; Chong-Gee Teo; Corinna Dan; Monica Parker; Joanne D Stekler; Alfred DeMaria; Veronica Miller Journal: Clin Infect Dis Date: 2014-05-27 Impact factor: 9.079
Authors: Souvik Sarkar; Denise A Esserman; Melissa Skanderson; Forrest L Levin; Amy C Justice; Joseph K Lim Journal: J Hepatol Date: 2016-04-27 Impact factor: 25.083
Authors: Esther Jane Aspinall; Joseph Samuel Doyle; Stephen Corson; Margaret Elena Hellard; David Hunt; David Goldberg; Tim Nguyen; Yngve Falck-Ytter; Rebecca Lynn Morgan; Bryce Smith; Mark Stoove; Stefan Zbyszko Wiktor; Sharon Hutchinson Journal: Eur J Epidemiol Date: 2014-11-11 Impact factor: 8.082
Authors: Douglas Halket; Jimmy Dang; Anuradha Phadke; Channa Jayasekera; W Ray Kim; Paul Kwo; Lance Downing; Aparna Goel Journal: J Gen Intern Med Date: 2022-03-01 Impact factor: 6.473
Authors: Van C Willis; Kelly Jean Thomas Craig; Yalda Jabbarpour; Elisabeth L Scheufele; Yull E Arriaga; Monica Ajinkya; Kyu B Rhee; Andrew Bazemore Journal: JMIR Med Inform Date: 2022-01-21